Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors

11 Apr 2025

Abstract excerpt

Neuroendocrine neoplasms (NENs) comprise a heterogeneous tumor group arising from neuroendocrine cells, commonly originating in the gastroenteropancreatic tract and bronchopulmonary system. Their incidence has risen significantly, owing to improved diagnostic techniques and increased clinical recognition. While previous reviews have explored the molecular and genetic basis of NENs, limited attention has been...

Topics

Join the communities discussing this publication.

Gestational Trophoblastic Disease Studies
Lung Cancer Research Studies
Neuroendocrine Tumor Research Advances

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40283452
DOI: 10.3390/jcm14082622

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine TumorsPMID 40283452Read ↗

Genetic and epigenetic drivers of neuroendocrine tumours (NET)Semantic proximity Read ↗

Clinical Epigenetics of Neuroendocrine Tumors: The Road AheadSemantic proximity Read ↗

Genetic and epigenetic alterations in pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine NeoplasmsSemantic proximity Read ↗

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic RegulationSemantic proximity Read ↗

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs)Semantic proximity Read ↗

Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis.Semantic proximity Read ↗

Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the LungSemantic proximity Read ↗

Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Semantic proximity Read ↗

Neuroendocrine tumours: cracking the epigenetic codeSemantic proximity Read ↗

Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.